Publications
- Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma2024 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- The role of trip6, abcc3 and cps1 expression in resistance of ovarian cancer to taxanes2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model2022 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- KRAS pathway expression changes in pancreatic cancer models by conventional and experimental taxanes2019 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Gene expression of membrane transporters: Importance for prognosis and progression of ovarian carcinoma2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Mathematics and Physics, Second Faculty of Medicine
- Genetic and functional analyses do not explain the association of high PRC1 expression with poor survival of breast carcinoma patients2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters2016 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- The expression profile of ATP-binding cassette transporter genes in breast carcinoma2013 | First Faculty of Medicine, Central Library of Charles University
- Novel Stony Brook taxanes are efficacious in paclitaxel-resistant ovarian cancer models both in vitro and in vivoPublication without faculty affiliation
Loading network view...